| dc.contributor.author | Kasimova S.A., Axatov Sh.Sh., Babadjanova Sh.A. | |
| dc.date.accessioned | 2023-05-10T16:21:08Z | |
| dc.date.available | 2023-05-10T16:21:08Z | |
| dc.date.issued | 2023-04 | |
| dc.identifier.uri | http://repository.tma.uz/xmlui/handle/1/7783 | |
| dc.description.abstract | In connection with the above, a burdened family history of metabolic syndrome (especially if there is a phenotypic similarity between the patient and a relative with MS) can be regarded as a risk factor for the complication of "steroid diabetes mellitus". Patients assigned to this group, if dexamethasone is necessary, should be pre-tested for glucose tolerance and subsequently their blood glucose levels should be effectively monitored during program treatment . | en_US |
| dc.language.iso | other | en_US |
| dc.publisher | KLINIK LABORATOR DIAGNOSTIKADA INNOVATSION TEXNOLOGIYALARDAN FOYDALANISH, MUAMMOLAR VA YECHIMLAR | en_US |
| dc.relation.ispartofseries | №2; | |
| dc.subject | Leukemia,lymphoblastic leukemia,glucocorticosteroid hormones,diabetes mellitus | en_US |
| dc.title | Frequency of occurrence of steroid diabetes mellitus on the background of acute leukemia | en_US |
| dc.type | Thesis | en_US |